Scribe Therapeutics Statistics
NASDAQ: SCTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
12.07-1.15 (-8.70%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Scribe Therapeutics by the numbers
Scribe Therapeutics has a market capitalization of $228.6 million based on 18.94M shares outstanding. With trailing EPS of $-6.35, Scribe Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 38.3% below its 50-day average and 46.0% below its 200-day average.
Average daily trading volume is 403.27K shares, or about $4.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
SCTX valuation vs. peer median
| Metric | SCTX | Peer median | Difference |
|---|---|---|---|
| Market cap | $228.58M | $243.09M | -6% |
| Avg. volume | 403.27K | 2.02M | -80% |
Peer median across 8 companies: ALLO, AUTL, PLX, LXEO, IPSC, EDIT, SABS, CABA.
Valuation
- Market cap
- $228.58M
- EPS (TTM)
- $-6.35
- Shares outstanding
- 18.94M
Price and trading
- Previous close
- 13.22
- Open
- 12.87
- Day range
- 12.00 – 13.40
- 52-week range
- 12.00 – 39.60
- Beta
- —
- Volume
- 301.40K
- Average volume
- 403.27K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Dec 2, 2026
Additional statistics
- Market Cap
- 228.58M
- Forward Pe
- -3.56
- Eps
- -6.35
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 39.60
- Week52 Low
- 12.00
- Avg Volume
- 403.27K
- Shares Outstanding
- 18.94M
- Ma50
- 19.56
- Ma200
- 22.35
- Earnings Date
- Dec 2, 2026
- Pct From52w High
- -69.52%
- Pct From52w Low
- 0.58%